封面
市場調查報告書
商品編碼
2058210

獸用疫苗佐劑市場:依產品類型、動物類型、給藥途徑、應用、最終用戶及地區分類

Veterinary Vaccine Adjuvants Market, By Product Type, By Animal Type, By Route of Administration, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年獸用疫苗佐劑市場規模估計為4.1億美元,預計2033年將達到6.4億美元。預計2026年至2033年,該市場將以6.6%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 4.1億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.60% 2033年市場規模預測: 6.4億美元

獸用疫苗佐劑是確保動物疫苗表現、穩定性和有效性的關鍵成分。它們有助於增強牲畜和寵物的免疫力,顯著提高疫苗的有效性。通用感染疾病威脅的日益加劇、牲畜數量的成長以及人們對動物預防醫學的日益重視,是推動世界各地對先進佐劑需求的主要因素。

全球動物疫苗佐劑市場涵蓋多種產品,包括油性乳劑、聚合物系統和奈米顆粒製劑。該市場正朝著佐劑研發和動物疫苗應用領域的新技術方向發展。寵物數量的成長、人們對動物疫苗接種意識的提高以及政府支持動物免疫的利好政策是影響市場動態的關鍵因素。免疫學領域新技術的引入,以及佐劑在多價疫苗和物種特異性疫苗中的應用,也將在未來幾年帶來巨大的商機。

市場動態

獸用疫苗佐劑市場的發展主要受畜禽和伴侶動物感染疾病及通用感染疾病率上升的驅動。這導致人們對免疫策略的需求日益成長。隨著全球蛋白質需求的成長推動畜牧業的快速發展,預防感染疾病和疾病變得尤為重要,促使基於疫苗佐劑的免疫接種得到更廣泛的應用。此外,寵物數量的增加、寵物飼主對寵物健康的日益關注以及醫療保健支出的成長也推動了疫苗產品的使用增加。

然而,該產業面臨許多阻礙因素,包括產品核准、研發和安全標準的嚴格監管,這些都會延緩進程並增加成本。此外,動物物種間的個體差異以及傳統佐劑的副作用也構成進一步的障礙。另外,開發中國家也面臨缺乏先進醫療保健解決方案和基礎設施等挑戰。

儘管如此,由於新一代疫苗佐劑等創新、政府和國際組織對疫苗接種計劃日益成長的興趣以及預防性動物護理的日益普及,市場上仍存在著許多成長機會。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球獸用疫苗佐劑市場主要公司的概況:公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球獸用疫苗佐劑市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用全球獸用疫苗佐劑市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 主要進展
  • 產業趨勢

第4章 全球獸用疫苗佐劑市場:依產品類型分類,2021-2033年

  • 鋁基佐劑
  • 油基佐劑
  • 乳劑型佐劑
  • 其他

第5章 全球獸用疫苗佐劑市場:依動物類型分類,2021-2033年

  • 家畜
  • 伴侶動物

第6章 全球獸用疫苗佐劑市場:依給藥途徑分類,2021-2033年

  • 注射藥物
  • 口服
  • 鼻內

第7章 全球獸用疫苗佐劑市場:依應用領域分類,2021-2033年

  • 細菌疫苗
  • 病毒疫苗
  • 寄生蟲疫苗

第8章 全球獸用疫苗佐劑市場:依最終用戶分類,2021-2033年

  • 動物用藥品和生物製藥公司
  • 合約研究組織/合約生產組織(CRO/CMO)
  • 研究和學術機構
  • 獸醫醫院和獸醫診所

第9章 全球獸用疫苗佐劑市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • HIPRA
  • Phibro Animal Health Corporation
  • Virbac
  • Vaxxinova
  • Seppic

第11章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9471

Veterinary Vaccine Adjuvants Market is estimated to be valued at USD 410 Mn in 2026 and is expected to reach USD 640 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 410 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.60% 2033 Value Projection: USD 640 Mn

Veterinary vaccine adjuvants are important constituents that ensure better performance, stability and improved efficacy of animal vaccines. They help boost the immunity levels in livestock and pets and provide a significant impact on the effectiveness of the vaccines. The increasing threat of zoonosis, rising livestock numbers, and greater focus on preventive care for animals are the major drivers behind the demand for sophisticated adjuvants in all regions around the world.

The global veterinary vaccines adjuvants market is dominated by a wide range of products such as oil emulsions, polymer-based systems, and nanoparticle-based formulations. The market is moving towards newer technologies in the creation of adjuvants and their usage in animal vaccines. Growing pet ownership, higher awareness about animal vaccination, and favorable government policies in support of animal immunization are the main factors influencing market dynamics. The introduction of new technology in the field of immunology and the inclusion of adjuvants in multivalent and species-specific vaccines will also offer lucrative opportunities in the coming years.

Market Dynamics

The veterinary vaccine adjuvants market is propelled by the rising incidences of infectious and zoonotic diseases among farm and companion animals. As a result, there is an increasing need for immunization strategies. With the rapid development of livestock production due to increasing protein demands around the world, the role of preventing infections and diseases becomes especially important, which leads to the greater implementation of immunizations based on vaccine adjuvants. Additionally, the increase in pets' numbers and pet owners' interest in animal health, alongside their expenditures on veterinary healthcare, leads to the increase in vaccine products use.

Nonetheless, the industry is faced with several limitations, such as strict regulation in terms of product approval, development, and safety standards, which might slow down the process and lead to extra costs. Moreover, individual differences between animal species and adverse reactions to conventional adjuvants constitute additional barriers. Additionally, there is insufficient availability of advanced healthcare solutions and infrastructure in less developed countries.

Nevertheless, there are numerous growth opportunities on the market because of innovations, including new-generation vaccine adjuvants, the increased interest of government agencies and international organizations in vaccination programs; and the rise in preventive animal care.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary vaccine adjuvants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis Inc., Merck Animal Health, Elanco Animal Health, Ceva Sante Animale, Boehringer Ingelheim Animal Health, HIPRA, Phibro Animal Health Corporation, Virbac, Vaxxinova, and Seppic
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccine adjuvants market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Aluminum-based Adjuvants
    • Oil-based Adjuvants
    • Emulsion-based Adjuvants
    • Others
  • Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Livestock Animals
    • Companion Animals
  • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
    • Injectable
    • Oral
    • Intranasal
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
    • Bacterial Vaccines
    • Viral Vaccines
    • Parasitic Vaccines
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
    • Veterinary Pharmaceutical and Biopharmaceutical Companies
    • Contract Research and Manufacturing Organizations (CROs/CMOs)
    • Research and Academic Institutes
    • Veterinary Clinics and Hospitals
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis Inc.
    • Merck Animal Health
    • Elanco Animal Health
    • Ceva Sante Animale
    • Boehringer Ingelheim Animal Health
    • HIPRA
    • Phibro Animal Health Corporation
    • Virbac
    • Vaxxinova
    • Seppic

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Veterinary Vaccine Adjuvants Market, By Product Type
    • Global Veterinary Vaccine Adjuvants Market, By Animal Type
    • Global Veterinary Vaccine Adjuvants Market, By Route of Administration
    • Global Veterinary Vaccine Adjuvants Market, By Application
    • Global Veterinary Vaccine Adjuvants Market, By End User
    • Global Veterinary Vaccine Adjuvants Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trends

4. Global Veterinary Vaccine Adjuvants Market, By Product Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Aluminum-based Adjuvants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Oil-based Adjuvants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Emulsion-based Adjuvants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Veterinary Vaccine Adjuvants Market, By Animal Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Livestock Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Companion Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Veterinary Vaccine Adjuvants Market, By Route of Administration, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Intranasal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Veterinary Vaccine Adjuvants Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Bacterial Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Viral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Parasitic Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Veterinary Vaccine Adjuvants Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Veterinary Pharmaceutical and Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research and Manufacturing Organizations (CROs/CMOs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Veterinary Clinics and Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Veterinary Vaccine Adjuvants Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HIPRA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vaxxinova
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Seppic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us